Mereo BioPharma Group PLC Stock London S.E.
Equities
GB00BZ4G2K23
Biotechnology & Medical Research
Sales 2024 * | 27.5M 34.41M | Sales 2025 * | 12.5M 15.64M | Capitalization | 315M 394M |
---|---|---|---|---|---|
Net income 2024 * | -8M -10.01M | Net income 2025 * | -28M -35.03M | EV / Sales 2024 * | 6.78 x |
Net cash position 2024 * | 128M 161M | Net cash position 2025 * | 142M 178M | EV / Sales 2025 * | 13.8 x |
P/E ratio 2024 * |
-300
x | P/E ratio 2025 * |
-60.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 46.94% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 53 | 15-02-28 | |
John P. Richard
FOU | Founder | 66 | 15-02-28 |
Founder | 64 | 15-07-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 19-04-22 |
Director/Board Member | - | 22-11-09 | |
Director/Board Member | 59 | 19-04-22 |
1st Jan change | Capi. | |
---|---|---|
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.79% | 22.02B | |
-17.84% | 20.9B | |
-9.35% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |